RAM
ADPT icon

Riggs Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Riggs Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$1.17K – 130
2025
Q2 		$1.17K Hold
100
– – ﹤0.01% 737
2025
Q1 		$743 Hold
100
– – ﹤0.01% 519
2024
Q4 		$611 Hold
100
– – ﹤0.01% 519
2024
Q3 		$512 Hold
100
– – ﹤0.01% 537
2024
Q2 		$362 Hold
100
– – ﹤0.01% 581
2024
Q1 		$321 Hold
100
– – ﹤0.01% 609
2023
Q4 		$490 Hold
100
– – ﹤0.01% 383
2023
Q3 		$545 Buy
+100
New +$661 ﹤0.01% 386

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riggs Asset Management's ADPT Position: Q3 2025 in Review

Riggs Asset Management sold out of Adaptive Biotechnologies (ADPT) in Q3 2025, closing a stake of 100 shares — an estimated $1.17K sold.

Riggs Asset Management first reported a position in ADPT in Q3 2023 and held it in 8 quarters. The position peaked at $1.17K in Q2 2025. 271 funds tracked by Wall St. Rank hold ADPT as of Q3 2025.

  • Riggs Asset Management reported no remaining Adaptive Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 100 Adaptive Biotechnologies shares in Q3 2025, an estimated $1.17K.
  • Riggs Asset Management first reported a position in Adaptive Biotechnologies in Q3 2023 and held it in 8 quarters.
  • Riggs Asset Management's Adaptive Biotechnologies position peaked at $1.17K in Q2 2025.
  • 271 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.